Diskussionsleiter: D. Thomas (Heidelberg)
| (BS53) | Role of NaV1.8 channels in the human failing heart – Identificantion of a novel antiarrhythmic approach | |
| N. Dybkova, S. Ahmad, S. Pabel, P. Tirilomis, N. Hartmann, K. Streckfuß-Bömeke, L. S. Maier, N. Frey, T. H. Fischer, G. Hasenfuß, S. T. Sossalla (Göttingen, Regensburg, Kiel) | ||
| (BS54) | TASK-1 gene therapy suppresses atrial fibrillation in a large animal model | |
| C. Schmidt, F. Wiedmann, C. Beyersdorf, Z. Zhao, H. Lan, I. El-Battrawy, X. Li, S. Lang, K. Rapti, A. Jungmann, S. Kallenberger, O. J. Müller, X. Zhou, I. Akin, M. Borggrefe, H. A. Katus, D. Thomas (Heidelberg, Mannheim) | ||
| (BS55) | Inducibility of ventricular arrhythmias: A modified approach to murine programmed electrical stimulation Short title: Inducibility of ventricular arrhythmias in mice | |
| L. Clasen, C. Eickholt, S. Angendohr, C. Jungen, H. Makimoto, A. Fürnkranz, D.-I. Shin, B. Donner, M. Kelm, S. Willems, N. Klöcker, C. Meyer (Düsseldorf, Hamburg, Krefeld; Basel, CH) | ||
| (BS56) | Verapamil strongly inhibits Kir2.3 channels by binding to the pore and interfering with PIP binding | |
| P. Xynogalos, S. Fried, D. Scherer, S. Chasan, H. A. Katus, E. Zitron (Heidelberg) | ||
| (BS57) | Effects of endurance exercise on atrial vulnerability in a genetically altered murine model of plakoglobin deficiency. | |
| P. R. Menon, C. Y. Hepburn, F. Syeda, A. P. Holmes, C. Apicella, T. Wright, S. Wells, S. N. Kabir, D. Pavlovic, A. Isaacs, M. Stoll, S. Lutz, P. Kirchhof, L. Fabritz (Birmingham, UK; Maastricht, NL; Münster, Göttingen) |